| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3361407 | International Journal of Antimicrobial Agents | 2007 | 10 Pages |
Abstract
Staphylococci are among the leading causes of nosocomial infections. Increasing insusceptibility to β-lactams and the glycopeptides complicates treatment of these infections. This review examines the current status and future perspectives for the therapy of infections caused by Staphylococcus aureus and coagulase-negative staphylococci.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
